Charles Schwab Investment Management Inc Axsome Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 382,047 shares of AXSM stock, worth $53.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
382,047
Previous 356,651
7.12%
Holding current value
$53.4 Million
Previous $37.2 Million
24.63%
% of portfolio
0.01%
Previous 0.01%
Shares
27 transactions
Others Institutions Holding AXSM
# of Institutions
414Shares Held
36.8MCall Options Held
752KPut Options Held
567K-
Vanguard Group Inc Valley Forge, PA4.18MShares$584 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$461 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA1.33MShares$186 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY1.12MShares$156 Million1.82% of portfolio
-
Macquarie Group LTD Australia, C31.08MShares$151 Million0.16% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...